Smith & Nephew makes the most of the orthopaedic growth wave
This article was originally published in Clinica
The orthopaedics market is showing unprecedented expansion. Is the time right for Smith & Nephew to accentuate its organic growth with some externally-added muscle, Ashley Yeo asked its chief executive Chris O'Donnell
You may also be interested in...
The US FDA has overhauled its ‘Purple Book’ to make it a searchable database of biologics information. The agency is also seeking input on next steps.
The International Council for Harmonisation has replaced its 1993 guideline on reproductive toxicity studies with an updated version.
Stada says it has become a "major consumer healthcare player" after signing a deal to acquire from GSK 15 brands, which generate annual sales of around €120m.